1. Home
  2. EIG vs BBNX Comparison

EIG vs BBNX Comparison

Compare EIG & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • BBNX
  • Stock Information
  • Founded
  • EIG 2000
  • BBNX 2015
  • Country
  • EIG United States
  • BBNX United States
  • Employees
  • EIG N/A
  • BBNX N/A
  • Industry
  • EIG Property-Casualty Insurers
  • BBNX Medical/Dental Instruments
  • Sector
  • EIG Finance
  • BBNX Health Care
  • Exchange
  • EIG Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • EIG 1.2B
  • BBNX 866.3M
  • IPO Year
  • EIG 2007
  • BBNX 2025
  • Fundamental
  • Price
  • EIG $49.65
  • BBNX $14.04
  • Analyst Decision
  • EIG Strong Buy
  • BBNX Strong Buy
  • Analyst Count
  • EIG 1
  • BBNX 6
  • Target Price
  • EIG $58.00
  • BBNX $26.67
  • AVG Volume (30 Days)
  • EIG 149.2K
  • BBNX 336.5K
  • Earning Date
  • EIG 04-24-2025
  • BBNX 05-06-2025
  • Dividend Yield
  • EIG 2.43%
  • BBNX N/A
  • EPS Growth
  • EIG 5.84
  • BBNX N/A
  • EPS
  • EIG 4.71
  • BBNX N/A
  • Revenue
  • EIG $880,700,000.00
  • BBNX $53,034,000.00
  • Revenue This Year
  • EIG N/A
  • BBNX $451.69
  • Revenue Next Year
  • EIG $4.73
  • BBNX $31.17
  • P/E Ratio
  • EIG $10.34
  • BBNX N/A
  • Revenue Growth
  • EIG 3.50
  • BBNX 6601.12
  • 52 Week Low
  • EIG $38.67
  • BBNX $13.64
  • 52 Week High
  • EIG $54.44
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • EIG 50.08
  • BBNX N/A
  • Support Level
  • EIG $47.78
  • BBNX N/A
  • Resistance Level
  • EIG $52.29
  • BBNX N/A
  • Average True Range (ATR)
  • EIG 0.97
  • BBNX 0.00
  • MACD
  • EIG -0.15
  • BBNX 0.00
  • Stochastic Oscillator
  • EIG 41.46
  • BBNX 0.00

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: